These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 2585443

  • 1. Topically active carbonic anhydrase inhibitors. 2. Benzo[b]thiophenesulfonamide derivatives with ocular hypotensive activity.
    Graham SL, Shepard KL, Anderson PS, Baldwin JJ, Best DB, Christy ME, Freedman MB, Gautheron P, Habecker CN, Hoffman JM.
    J Med Chem; 1989 Dec; 32(12):2548-54. PubMed ID: 2585443
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. 4-substituted thiophene- and furan-2-sulfonamides as topical carbonic anhydrase inhibitors.
    Hartman GD, Halczenko W, Smith RL, Sugŕue MF, Mallorga PJ, Michelson SR, Randall WC, Schwam H, Sondey JM.
    J Med Chem; 1992 Oct 16; 35(21):3822-31. PubMed ID: 1433194
    [Abstract] [Full Text] [Related]

  • 4. Topically active carbonic anhydrase inhibitors. 3. Benzofuran- and indole-2-sulfonamides.
    Graham SL, Hoffman JM, Gautheron P, Michelson SR, Scholz TH, Schwam H, Shepard KL, Smith AM, Smith RL, Sondey JM.
    J Med Chem; 1990 Feb 16; 33(2):749-54. PubMed ID: 2299640
    [Abstract] [Full Text] [Related]

  • 5. New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-substituted thieno[2,3-b]thiophene-2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamides.
    Prugh JD, Hartman GD, Mallorga PJ, McKeever BM, Michelson SR, Murcko MA, Schwam H, Smith RL, Sondey JM, Springer JP.
    J Med Chem; 1991 Jun 16; 34(6):1805-18. PubMed ID: 2061922
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 3-substituted thieno[2,3-b][1,4]thiazine-6-sulfonamides. A novel class of topically active carbonic anhydrase inhibitors.
    Hunt CA, Mallorga PJ, Michelson SR, Schwam H, Sondey JM, Smith RL, Sugrue MF, Shepard KL.
    J Med Chem; 1994 Jan 21; 37(2):240-7. PubMed ID: 8295211
    [Abstract] [Full Text] [Related]

  • 9. Topical carbonic anhydrase inhibitors.
    Kass MA.
    Am J Ophthalmol; 1989 Mar 15; 107(3):280-2. PubMed ID: 2923154
    [No Abstract] [Full Text] [Related]

  • 10. Topically active carbonic anhydrase inhibitors. 1. O-acyl derivatives of 6-hydroxybenzothiazole-2-sulfonamide.
    Woltersdorf OW, Schwam H, Bicking JB, Brown SL, deSolms SJ, Fishman DR, Graham SL, Gautheron PD, Hoffman JM, Larson RD.
    J Med Chem; 1989 Nov 15; 32(11):2486-92. PubMed ID: 2810337
    [Abstract] [Full Text] [Related]

  • 11. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF, Gautheron P, Grove J, Mallorga P, Viader MP, Schwam H, Baldwin JJ, Christy ME, Ponticello GS.
    J Ocul Pharmacol; 1990 Nov 15; 6(1):9-22. PubMed ID: 2362161
    [Abstract] [Full Text] [Related]

  • 12. European Glaucoma Prevention Study.
    Quigley HA.
    Ophthalmology; 2005 Sep 15; 112(9):1642-3; author reply 1643-5. PubMed ID: 16139678
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A topical carbonic anhydrase inhibitor finally arrives.
    Palmberg P.
    Arch Ophthalmol; 1995 Aug 15; 113(8):985-6. PubMed ID: 7639673
    [No Abstract] [Full Text] [Related]

  • 15. MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors.
    Lippa EA, Schuman JS, Higginbotham EJ, Kass MA, Weinreb RN, Skuta GL, Epstein DL, Shaw B, Holder DJ, Deasy DA.
    Ophthalmology; 1991 Mar 15; 98(3):308-12; discussion 312-3. PubMed ID: 2023750
    [Abstract] [Full Text] [Related]

  • 16. Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma.
    Baldwin JJ, Ponticello GS, Anderson PS, Christy ME, Murcko MA, Randall WC, Schwam H, Sugrue MF, Springer JP, Gautheron P.
    J Med Chem; 1989 Dec 15; 32(12):2510-3. PubMed ID: 2585439
    [No Abstract] [Full Text] [Related]

  • 17. Central corneal thickness.
    Hustead JD.
    Arch Ophthalmol; 1998 Sep 15; 116(9):1263. PubMed ID: 9747703
    [No Abstract] [Full Text] [Related]

  • 18. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension.
    Balfour JA, Wilde MI.
    Drugs Aging; 1997 May 15; 10(5):384-403. PubMed ID: 9143858
    [Abstract] [Full Text] [Related]

  • 19. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF, Gautheron P, Mallorga P, Nolan TE, Graham SL, Schwam H, Shepard KL, Smith RL.
    Br J Pharmacol; 1990 Jan 15; 99(1):59-64. PubMed ID: 2110013
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and crystallographic analysis of new sulfonamides incorporating NO-donating moieties with potent antiglaucoma action.
    Mincione F, Benedini F, Biondi S, Cecchi A, Temperini C, Formicola G, Pacileo I, Scozzafava A, Masini E, Supuran CT.
    Bioorg Med Chem Lett; 2011 Jun 01; 21(11):3216-21. PubMed ID: 21549597
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.